Verrica Pharmaceuticals Inc to Host KOL Event (Virtual) Transcript
Good morning and welcome to the Verrica Pharmaceuticals KOL Investor Event. (Event Instructions)
As a reminder, this call is being recorded and a replay will be made available on the Verrica following the conclusion of the event.
I'd now like to turn the call over to Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals. Please go ahead, Ted.
Thank you, [Tara]. Good morning, everyone. I'd like to personally welcome you and thank everyone for participating in today's virtual KOL Investor Event discussing our recent FDA approval of YCANTH, the first and only approved treatment for molluscum contagiosum in adult and pediatric patients, two years of age and older.
Molluscum is caused by a pox virus that produces a distinct raised skin-toned-to-pink-colored lesions that can cause pain, inflammation, itching, and bacterial infections. It's easily transmitted through direct skin-to-skin contact or through fomites and can spread to other parts of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |